Report Detail
Global (United States, European Union and China) Natural Killer (NK) Cell Therapeutics Market Research Report 2019-2025
- RnM3674714 |
- 16 August, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Natural killer cells are a type of cytotoxic lymphocyte, which is a component of the innate immune system.
In 2019, the market size of Natural Killer (NK) Cell Therapeutics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Natural Killer (NK) Cell Therapeutics.
This report studies the global market size of Natural Killer (NK) Cell Therapeutics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Natural Killer (NK) Cell Therapeutics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Chipscreen Biosciences (China)
Affimed NV (Netherlands)
Altor BioScience Corporation (USA)
Innate Pharma SA (France)
Takeda Pharmaceutical (Japan)
Sorrento Therapeutics Inc. (USA)
NantKwest Inc. (USA)
Bristol-Myers Squibb (USA)
NKT Therapeutics (USA)
Market Segment by Product Type
Mogamulizumab
Lorvotuzumab Mertansine
Others
Market Segment by Application
Cancer
Cardiovascular Diseases
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Natural Killer (NK) Cell Therapeutics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Natural Killer (NK) Cell Therapeutics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Natural Killer (NK) Cell Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Mogamulizumab
- 1.3.3 Lorvotuzumab Mertansine
- 1.3.4 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Natural Killer (NK) Cell Therapeutics Market Share by Application (2019-2025)
- 1.4.2 Cancer
- 1.4.3 Cardiovascular Diseases
- 1.4.4 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Natural Killer (NK) Cell Therapeutics Market Size
- 2.1.1 Global Natural Killer (NK) Cell Therapeutics Revenue 2014-2025
- 2.1.2 Global Natural Killer (NK) Cell Therapeutics Sales 2014-2025
- 2.2 Natural Killer (NK) Cell Therapeutics Growth Rate by Regions
- 2.2.1 Global Natural Killer (NK) Cell Therapeutics Sales by Regions 2014-2019
- 2.2.2 Global Natural Killer (NK) Cell Therapeutics Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Natural Killer (NK) Cell Therapeutics Sales by Manufacturers
- 3.1.1 Natural Killer (NK) Cell Therapeutics Sales by Manufacturers 2014-2019
- 3.1.2 Natural Killer (NK) Cell Therapeutics Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Natural Killer (NK) Cell Therapeutics Revenue by Manufacturers (2014-2019)
- 3.2.2 Natural Killer (NK) Cell Therapeutics Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Natural Killer (NK) Cell Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.3 Natural Killer (NK) Cell Therapeutics Price by Manufacturers
- 3.4 Key Manufacturers Natural Killer (NK) Cell Therapeutics Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Natural Killer (NK) Cell Therapeutics Market
- 3.6 Key Manufacturers Natural Killer (NK) Cell Therapeutics Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Mogamulizumab Sales and Revenue (2014-2019)
- 4.1.2 Lorvotuzumab Mertansine Sales and Revenue (2014-2019)
- 4.1.3 Others Sales and Revenue (2014-2019)
- 4.2 Global Natural Killer (NK) Cell Therapeutics Sales Market Share by Type
- 4.3 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type
- 4.4 Natural Killer (NK) Cell Therapeutics Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Natural Killer (NK) Cell Therapeutics Sales by Application
6 United States
- 6.1 United States Natural Killer (NK) Cell Therapeutics Breakdown Data by Company
- 6.2 United States Natural Killer (NK) Cell Therapeutics Breakdown Data by Type
- 6.3 United States Natural Killer (NK) Cell Therapeutics Breakdown Data by Application
7 European Union
- 7.1 European Union Natural Killer (NK) Cell Therapeutics Breakdown Data by Company
- 7.2 European Union Natural Killer (NK) Cell Therapeutics Breakdown Data by Type
- 7.3 European Union Natural Killer (NK) Cell Therapeutics Breakdown Data by Application
8 China
- 8.1 China Natural Killer (NK) Cell Therapeutics Breakdown Data by Company
- 8.2 China Natural Killer (NK) Cell Therapeutics Breakdown Data by Type
- 8.3 China Natural Killer (NK) Cell Therapeutics Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Natural Killer (NK) Cell Therapeutics Breakdown Data by Company
- 9.2 Rest of World Natural Killer (NK) Cell Therapeutics Breakdown Data by Type
- 9.3 Rest of World Natural Killer (NK) Cell Therapeutics Breakdown Data by Application
- 9.4 Rest of World Natural Killer (NK) Cell Therapeutics Breakdown Data by Countries
- 9.4.1 Rest of World Natural Killer (NK) Cell Therapeutics Sales by Countries
- 9.4.2 Rest of World Natural Killer (NK) Cell Therapeutics Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Chipscreen Biosciences (China)
- 10.1.1 Chipscreen Biosciences (China) Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Natural Killer (NK) Cell Therapeutics
- 10.1.4 Natural Killer (NK) Cell Therapeutics Product Introduction
- 10.1.5 Chipscreen Biosciences (China) Recent Development
- 10.2 Affimed NV (Netherlands)
- 10.2.1 Affimed NV (Netherlands) Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Natural Killer (NK) Cell Therapeutics
- 10.2.4 Natural Killer (NK) Cell Therapeutics Product Introduction
- 10.2.5 Affimed NV (Netherlands) Recent Development
- 10.3 Altor BioScience Corporation (USA)
- 10.3.1 Altor BioScience Corporation (USA) Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Natural Killer (NK) Cell Therapeutics
- 10.3.4 Natural Killer (NK) Cell Therapeutics Product Introduction
- 10.3.5 Altor BioScience Corporation (USA) Recent Development
- 10.4 Innate Pharma SA (France)
- 10.4.1 Innate Pharma SA (France) Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Natural Killer (NK) Cell Therapeutics
- 10.4.4 Natural Killer (NK) Cell Therapeutics Product Introduction
- 10.4.5 Innate Pharma SA (France) Recent Development
- 10.5 Takeda Pharmaceutical (Japan)
- 10.5.1 Takeda Pharmaceutical (Japan) Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Natural Killer (NK) Cell Therapeutics
- 10.5.4 Natural Killer (NK) Cell Therapeutics Product Introduction
- 10.5.5 Takeda Pharmaceutical (Japan) Recent Development
- 10.6 Sorrento Therapeutics Inc. (USA)
- 10.6.1 Sorrento Therapeutics Inc. (USA) Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Natural Killer (NK) Cell Therapeutics
- 10.6.4 Natural Killer (NK) Cell Therapeutics Product Introduction
- 10.6.5 Sorrento Therapeutics Inc. (USA) Recent Development
- 10.7 NantKwest Inc. (USA)
- 10.7.1 NantKwest Inc. (USA) Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Natural Killer (NK) Cell Therapeutics
- 10.7.4 Natural Killer (NK) Cell Therapeutics Product Introduction
- 10.7.5 NantKwest Inc. (USA) Recent Development
- 10.8 Bristol-Myers Squibb (USA)
- 10.8.1 Bristol-Myers Squibb (USA) Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Natural Killer (NK) Cell Therapeutics
- 10.8.4 Natural Killer (NK) Cell Therapeutics Product Introduction
- 10.8.5 Bristol-Myers Squibb (USA) Recent Development
- 10.9 NKT Therapeutics (USA)
- 10.9.1 NKT Therapeutics (USA) Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Natural Killer (NK) Cell Therapeutics
- 10.9.4 Natural Killer (NK) Cell Therapeutics Product Introduction
- 10.9.5 NKT Therapeutics (USA) Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Natural Killer (NK) Cell Therapeutics Sales Channels
- 11.2.2 Natural Killer (NK) Cell Therapeutics Distributors
- 11.3 Natural Killer (NK) Cell Therapeutics Customers
12 Market Forecast
- 12.1 Global Natural Killer (NK) Cell Therapeutics Sales and Revenue Forecast 2019-2025
- 12.2 Global Natural Killer (NK) Cell Therapeutics Sales Forecast by Type
- 12.3 Global Natural Killer (NK) Cell Therapeutics Sales Forecast by Application
- 12.4 Natural Killer (NK) Cell Therapeutics Forecast by Regions
- 12.4.1 Global Natural Killer (NK) Cell Therapeutics Sales Forecast by Regions 2019-2025
- 12.4.2 Global Natural Killer (NK) Cell Therapeutics Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Natural Killer (NK) Cell Therapeutics. Industry analysis & Market Report on Natural Killer (NK) Cell Therapeutics is a syndicated market report, published as Global (United States, European Union and China) Natural Killer (NK) Cell Therapeutics Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Natural Killer (NK) Cell Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
